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Summary: A competitive enzyme immunoassay for apolipoprotein A-II was developed. Microtitre plates were
used äs a solid phase and coated with anti-apolipoprotein A-II antibodies. Purified apolipoprotein A-II,
labelled with horseradish peroxidase was used äs competing ligand.
The assay was examined with respect to the optimal amounts of specific anti-apolipoprotein A-II antibodies and
apolipoprotein A-II-enzynie conjugate. The displacement curves showed a good parallelism between serum
and purified apolipoprotein A-II. Delipidation of serum did not affect the content of apolipoprotein
A-II. Cross-reactivity with apolipoprotein A-I was minimal. The intra- and inter-assay coefficients of Variation
in the medium ränge were 9.0 and 11.8% respectively. The assay might be well-suited for clinical routine.
Kompetitiver Enzymimmunoassay für Apolipoprotein A-ll
Zusammenfassung: Es wurde ein kompetitiver Enzymimmunoassay für Apolipoprotein A-II entwickelt. Für
die feste Phase wurden Mikrotiterplatten benutzt, die mit Anti-Apolipoprotein A-II Antikörpern beschichtet
waren. Als konkurrierendes Bindungsreagenz wurde gereinigtes Apolipoprotein A-II, markiert mit Meerret-
tich-Peroxidase, eingesetzt. Der Assay wurde hinsichtlich der optimalen Menge des spezifischen Anti-Apolipo-
protein A-II Antikörpers und des Apolipoprotein A-II Konjugates überprüft. Die Verdrängungskurven
zeigten eine gute Parallelität zwischen Gesamtserum und gereinigtem Apolipoprotein A-II.
Eine Delipidierung des Serums beeinflußte die Konzentration des Apolipoprotein A-JI nicht. Die Kreuzreak-
tion mit Apolipoprotein A-I war geringfügig. Die Variationskoeffizienten betrugen im mittleren Meßbereich in
der Reihe 9,0% und von Tag zu Tag 11,8%. Die Methode dürfte für Routine-Bestimmungen von Apolipopro-
tein A-II geeignet sein.
Introduction
Epidemiological results showing a negative correla-
tion between plasma high density lipoprotein (HDL)
cholesterol levels and the incidence of coronary heart
disease have caused an increased awareness of the
value of HDL determinations in the evaluation of the
individual coronary risk. This has led in recent years
to the development of immuiioassays for the apolipo-
proteins of HDL. An especially large number of stu-
dies has been devoted to the quantification of the
apolipoproteins A-I and A-II which together ac-
count for 90 percent of the total protein content of
HDL.
A number of quantitative assays such äs single radial
immunodiffusion (l, 2, 3), rocket immunoelectro-
phoresis (4) and radioimmunoassay (5—10) for apoli-
poprotein A-II have been described. Considering the
considerable discordances between the reported nor-
mal apolipoprotein A-II values (1 — 10), it appears
that this apolipoprotein has been difficult to quantify.
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Here we report the development of an enzyme immu-
noassay for apolipoprotein A-II. The enzyme immu-
noassay technique shares with the radioimmunoassay
several important advantages compared with single
radial immundiffusion and rocket immunoelectro-
phoresis, such äs sensitivity, the small amount of an-
tiserum required, and the large number of samples
which can be handled in each assay. Relative to the
radioimmunoassay, the enzyme immunoassay bene-
fits from low Investment costs, stability of reagents
and absence of biohazards associated with the han-
dling of radioactive materials. It therefore seemed
appropriate to try this technique for the estimation
of apolipoprotein A-II concentrations in serum.
The residue was finally dried under N2 and the delipidated HOL
was fractionated by Sephacryl S 300 in 6 mol/1 urea, 0.05 mol/i
Tris-HCl pH 8.6. The fractions corresponding to apolipoprotein
A-II were further purified after lyophilisation by chromatography
on DEAE-Trisacryl in 6 mol/1 urea employing a linear gradient
(0.001 mol/1 Tris-HCl pH 8.6-0.02 mol/1 tris-HCl pH 8.6),Frac-
tions corresponding to apolipoprotein A-II were extensively dia-
lyzed agäinst 0.001 mol/1 NH4HCO3 and lyophllized. A final puri-
fication step was carried out by preparative polyacrylamide elec-
trophoresis (12). The purified apolipoprotein A-II yielded a single
band on polyacrylamide gel electrophoresis in sodium dodecyl sul-
phate (SDS) (12).
Preparation of apolipoprotein A^II antisera
Rabbits were immunized at multiple intradermal sites with l mg
apolipoprotein ^ mixed with complete Freund'* -adjuvant. At
intervals of 3 weeks, the animals received booster doses, consisting
of half the dose of antigen and incomplete Freund?* adjuvant. Ani-
mals were bled after 12 weeks. The antisera were monpspecific äs
tested by double diffusion in agarose.
Materials and Methods
Mater ia ls
Horseradish peroxidäse (EC 1.11.1.7. Reinheitszahl ca. 3.0) was
purchased from Boehringer Mannheim, FRG; bovine serum al-
bumin, RIA grade from Sigma, Munich, FRG; Tween 20 from
Serva, Heidelberg, FRG; o-phenylenediamine and hydrogen per-
oxide from Merck, Darmstadt, FRG; Sephacryl S 200 and S 300
from Pharmacia, Freiburg, FRG; DEAE-Trisacryl from LKB,
Düsseldorf, FRG; Freund'* adjuvant from Behringwerke Mar-
burg, FRG).
The assays were performed in 96-well, round-bottomed micro-
titre plates M-124 B from Flow Laboratories, FRG.
All other reagents were analytical grade.
Reagents
Carbonate-hydrogencarbonate buffer:
1.6 g/l sodium carbonate and 2.95 g/l sodium hydfogencarbonate
pH 9.6. This buffer should be made up freshly every week.
Phosphate-buffered saline containing Tween:
1.48 g of disodium hydrogen phosphate, 0.43 gof potassium dihyd-
rogen phosphate, 8.77 g of sodium Chloride and 0.5 ml Tween 20
were dissolved in 800 ml of distilled water. After adjustment of
the pH to 7.2, the solution was diluted to 11 with distilled water.
Phosphate-citrate buffer:
8.52g of disodium hydrogen phosphate and 5.25g of citric acid
were dissolved in 800 ml of distilled water. After adjustment of
the pH to 5.0, the solution was diluted to 11 with distilled water.
Chromogen solution:
The Substrate solution was made up immediately before use. 15 mg
of o-phenylenediamine were dissolved in 100 ml of the above
phosphate-citrate buffer and 40 of hydrogen peroxide (300 g/l)
were added.
Preparation of apolipoprotein A-II
HDL (1.063 < d < 1.21 kg/l) was isolated by sequential ultracen-
tnfugation from normolipaemic individual donors and was delipl·
datedbyethanol-ether(volumes,300ml + 200ml)ät-10°C(ll).
Preparation of the apolipoprotein - ^ € conju-
gate
Apolipoprotein A-II was labelled with horseradish peroxidase ac-
cording to the method of Näkane et al. (13). The apolipoprotein
A-II-enzyme conjugate was isolated by passing through a 100 x
2.5 cm column of Sephacryl S 200. The first peak was collected
and concentrated in an Amicon cell using a PM 10 filter. After
addition of bovine albumin and merthiolate to a final cpncentra-
tion of 10 g/l aiid 0.1 g/l respectively, the apolipoprotein A-II-
enzyme conjugate was stored at 4°C.
Standards
Dilutipns of a serum pool in phosphate buffered saline/Tween con-
taining 10 g/l bovine serum albumin and 0.1 g/l merthiolate were
used äs apolipoprotein A-II Standards.
To deterraine the apolipoprotein A^II cöntent qf the serum pöol,
HDL (l .063 < d < l .21 g/l) was isolated by sequential ultracentri-
fugation (14) and its apoprotein cöntent measured by the method
of Lowry (15), using bovine serum albumin äs a Standard; the
apolipoprotein - contributipn to the HDL protein was äs?
sumed to be approximately 0,20 (5, 6, 9, 10).
Enzyme immunoassay procedure
The typical enzyme immunoassay was carried out in the follpwing
way. Each well of a microtitre plate was filled with 0.1 ml of a
solution of 50 mg/1 anti-apolipoprotein A-Ü IgG in carbonate-hy-
drogencarbohate 'buffer pH 9.6. IgG had been isolated ipreviously
from the anti-apolipoprotein A-II-antiserum by ammonium sul-
phate precipitatipn and DEAE-Trisacryl chromatography. The
microtitre plates were covered with parafilm and incubated for 3
hours at 37 °C. The contents of the plates were then aspirated and
dried in an air stream at room temperature for approximately 15
minutes, then washed 7 times with phosphate buffered saline/
Tween. The plate filled with phosphate buffered saline/Tween
was then incubated for approximately 10 minutes at 37 °C to en-
hance the desorption of all IgG not strongly fixed to the walls öf
the plate wells. Hinally the plate was washed again 3 times with
phosphate buffered saline/Tween. Standard or serum was diluted
1:1000 with phosphate buffered saline/Tween containing 10 g/l
bovine serum albumin and 0.1 g/l merthiolate. Apolipoprotein A-
II-enzyme conjugate was diluted 1:50 with phosphate buffered
saline/Tweeii containing 10 g/l bovine serum albumin. 50 ul dilut-
ed Standard or serum were mixed with 50 ul diluted apolipopro-
tein Arll-enzyme conjugate and added in duplicate to each well of
a coated microtitre plate, with the exception .of the wells belong-
ing to the externäl rows of the plate, which? were left free. The
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covered plates were incubated for 4 hours at 30 °C. The contents
were then aspirated and the plates were washed 7 times with
phosphate buffered saline/Tween. 0.1 ml of chromogen solution
was pipetted into each well and the plate was left at room temper-
ature in the dark. After 30 minutes, 0.1 ml of 250 g/kg hydro-
chloric acid was added to each well and the absorbance was mea-
sured within 30 minutes at 492 nm. As a blank 0.1 ml unreacted
chromogen solution with 0.1 ml 250 g/kg hydrochloric acid was
used.
The results were expressed s a fraction of the absorbance at
492 nm when no competing antigen was present (i.e. B/B ).
B: absorbance in the presence of Standard, or unknown sample.
B0: absorbance in the absence of Standard or unknown sample.
Results were calculated using the logit transformation: logit B/B0
= In B/B : (l - B/B ). Standard curves were plotted using y = log
B/B or y = B/B and χ = log dose Standard in nanogram.
Treatment of the samples
Some serum samples were delipidated with ethanol-ether (11) and
some serum samples were fractionated by sequential ultracentrifu^·
gation in ordef to isolate very low density lipoproteins (VLDL) (d
< 1.006 kg/l), low density lipoproteins (LDL) (1.006 < d < 1.063
kg/l) and HOL (1.063 < d < 1.21 kg/l (14).
Results
Optimizing assay conditions
Effect of different amounts ofanti apolipoprotein ΑΊΙ
IgG to coat the microtitre plate wells
0.1 ml of anti apolipoprotein A-II IgG in different
amounts between 20 and 100 mg/1 diluted in carbo-
nate-hydrogen carbonate buffer was· dispensed into
the wells of a microtitre plate and incubated for 3
hours at 37 °C. After washing, the plates were.used s
in the typical enzyroe immunoassay procedure. The
results are shown in figure 1.
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Fig. l. Effect on the Standard curves of different amounts of anti
apolipoprotein A-II IgG used to coat the microtitre plate
wells (·—·: 20 mg/1, O—O: 40 mg/1, A—A: 60 mg/1,
Δ—Δ: 80 mg/1, ·—·: 100 mg/1).
Effect of different dilutions of apolipoprotein A-II-en-
zyme conjugate
50 μΐ of apolipoprotein A-II-enzyme conjugate dilut-
ed between 1/33 and 1/400 were added to 50 μΐ of a
series of Standards and the mixture was dispensed into
coated microtitre plate wells. The typical enzyme im-
munoassay procedure was then followed. The results
are shown in figure 2.
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Fig. 2. Effect of various dilutions of apolipoprotein A-II-enzyme
conjugate on the Standard curves (O—O: 1:33, O—O:
1:50, A—A: 1:100, Δ—Δ: 1:200, D—D: 1:400).
Coating of the plates with 50 ing/1 anti-apolipopro-
tein A^H IgG, and a dilution of 1/50 for apolipopro-
tein A-II-enzyme conjugate were selected s optimal
for econpmy, pfecision and displacement of labelled
apolipoprotein A-II.
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Fig. 3. Logit-log plot of the displacement curves of purified apoli-
poprotein A-II (E—E) and serum (A—A).
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Paral lel ism between serum and puri f ied
apolipoprotein A-II
When the results were fitted in a logit-log plot, there
was a good parallelism between serum and purified
apolipoprotein A-II suggesting immunological iden-
tity (fig. 3). However, on several occasions serum
demonstrated a slighty greater ability to displace the
enzyme labelled apolipoprotein A-II than purified
apolipoprotein A-II.
Effect of delipidation
Delipidation of serum with ethanol-ether caused
practically no alteration in the apparent content of
apolipoprotein A-II (tab. 1).
Tab. l. Effect of serum delipidation on the concentration of apoli-
poprotein A-II.
Apolipoprotein A-II (g/l)
Total Delipidated
•serum serum
A. G.
W. S.
H.B.
E. T.
W.W.
U. H.
T. S.
H. S.
Mean
SD
0.346
0.272
0.373
0.350
0.395
0.324
0.407
0.296
0.345
0.046
0.341
0.316
0.332
0.321
0.414
0.364
0.382
0.339
0.351
0.033
Specificity
The cross-reactivity with purified apolipoprotein A-I
was about 1%. As demonstrated by the displacement
produced by isolated LDL.and VLDL, the cross-
reactivity with these lipoprotein fractions was only
jninimal in the working ränge of the assay (fig. 4).
Precision
To assess the precision of the assay, 3 serum pools
containing high, medium and low amounts of apoli-
poprotein A-II were used. The intra-assay coeffi-
cient of Variation was estimated by 20 replicated ana-
lyses of apolipoprotein A-II in the three serum
pools. The inter-assay coefficient of Variation was es-
timated by making duplicate analyses in the 3 pools
on 10 different days. The results are shown in tab. 2.
Discussion
Numerous studies have yielded conflicting results
concerning the normal values of apolipoprotein A-II
in serum (1-10). This may have been caused in part
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Fig. 4. Displacement curves of apolipoprotein A-II-enzyme con-
jugate by whole serum ( — ), HOL (d: 1.063 - 1.21 kg/
1) ( — ), VLDL (d ^  1.006 kg/I) ( ^ ), LDL (d: 1.006
- 1.063 kg/l) (<0>—i^) and purified apolipoprotein A-I
(D—D). Protein concentrations were determined by <the
method öf Lowry :(15).
Tab. 2. Intra^ and inter-assay precision (serum pool)
Intra-assay precision Apolipoprotein A-II CV
(g/0 (%)
Mean SD
High concentration of
apolipoprotein A-II 0.435 0.056 12.8
Medium concentration of
äpolipoprotemA^-II 0.344 0.031 9.0
Low concentration of .
apolipoprotein A-II 0.204 0.017 8.5
Inter-assay precision
High concentration of
apolipoprotein A-II 0.413 0.06 14.6
Medium concentration of
apolipoprotein A-II 0.351 0.041 11.8
Low concentration of
apolipoprotein A-II 0.228 0.029 12.6
by differeiices in the molecular form of apolipopro^
tein A-II between the Standards and the test samples.
These discrepancies stress our present difficulties in
Unding a suitäble apolipoprotein A-II Standard.
Goldberg et al. (6) used purified apolipoprotein A-II
äs a Standard in their radioimmunoassay of apolipo-
protein A-II. It is well known that, in aqueous solu-
tion, purified apoproteins have a tendency to aggre-
gate and this may cause a change of their immunologi-
cal characteristics.
In our assay, we preferred to use äs a Standard whole
serum whose apolipoprotein - content had been
estimated with a ireasonäble äppf orimation. The apo-
lipoprotein A-II mass of HOL has generally been
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found to represent 0.20 of the total apoprotein (5, 6,
9, 10), and interestingly in all forms of hyperlipidae-
mia the proportion of apolipoprotein A-II in HDL
was found to be unaltered (16).
In their radioimmunoassay for apolipoprotein A-II,
Goldberg et al. (6) found that in a logit-log plot, se-
rum dilutions produced displacement curves that
were not parallel to those of purified apolipoprotein
A-II and they observed a more effective displacement
of iodinated apolipoprotein A-II by increasing doses
of purified apolipoprotein A-II than by whole serum.
Karlin et al. (17) also pointed out the nonparallelism
between dilutions of HDL and purified apolipopro-
tein A-II, but noted a less effective displacement by
purified HDL apolipoproteins than by HDL. In gen-
eral we observed in our assay an acceptable parallel-
ism between purified apolipoprotein A-II and diluted
serum. Nevertheless, äs mentioned previously, we
preferred to use dilutions of a serum pool äs Stand-
ards.
It has been reported several times that in contrast to
apolipoprotein A-I, delipidation of serum did virtual-
ly not appear to expose additional antigenic determi-
nants of apolipoprotein A-II (5, 7, 9). Our results of
delipidation confirmed this and made a delipidation
step of the serum samples before assay unnecessary.
The sensitivity of our single antibody method using
specific anti-apolipoprotein A-II IgG bound to a solid
phase, was relatively low compared with the sensitivi-
ty of a double antibody radioimmunoassay described
previously (5). This feature of the assay, however,
made it possible to avoid the very high dilutions of the
serum samples which were necessary in the radioim-
munoassay.
For optimal precision of the assay, the following
methodical details were important. First, because of
their Variation in protein adsorption (18,19) the ex-
ternal rows of the microtitre plate were not used. Se-
cond, coating of the plate with excessive amounts of
anti-apolipoprotein A-II IgG was avoided since this
resulted in a loss of precision. Third, the plates were
coated with no more than 0.1 ml of IgG solution in
carbonate-hydrogen carbonate buffer and the total
volume of sample plus apolipoprotein-enzyme con-
jugate amounted also to 0.1 ml. This ensured that no
labelled or unlabelled apolipoprotein A-II became
bound to antibody fixed at the upper part of the well
during the washing procedure. Fourth, the plate was
coated at 37 °C, then dried in an air stream and dur-
ing the washing procedure incubated at 37 °C. Dur-
ing the incubation with Standard or sample and apo-
lipoprotein-enzyme conjügate, however, the temper-
ature was limited to 30 °C. This caused a net im-
provement of the precision, probably by reducing
the desorption of anti-apoiipoprotein A-II IgG from
the plates during the incubation with sample and
apolipoprotein-enzyme conjügate.
In order to appreciate the predictive ability of apoli-
poproteins in the evaluation of the risk of coronary
heart disease, simple, fast, reliable and precise meth-
ods for the assay of apolipoproteins are required. The
enzyme immunoassay is characterised by minimal de-
mands on equipment and technical expertise and may
be adapted for the quantification of apolipoprotein
A-II in clinical routine. The preparation of a suitable
Standard, however, deserves further studies.
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